125 related articles for article (PubMed ID: 3524471)
1. Effect of intralesional alpha 2-interferon on actinic keratoses.
Edwards L; Levine N; Weidner M; Piepkorn M; Smiles K
Arch Dermatol; 1986 Jul; 122(7):779-82. PubMed ID: 3524471
[TBL] [Abstract][Full Text] [Related]
2. The effect of topical interferon alpha 2b on actinic keratoses.
Edwards L; Levine N; Smiles KA
J Dermatol Surg Oncol; 1990 May; 16(5):446-9. PubMed ID: 2341658
[TBL] [Abstract][Full Text] [Related]
3. Recombinant interferon alfa-2b in plaque-phase mycosis fungoides. Intralesional and low-dose intramuscular therapy.
Vonderheid EC; Thompson R; Smiles KA; Lattanand A
Arch Dermatol; 1987 Jun; 123(6):757-63. PubMed ID: 3579357
[TBL] [Abstract][Full Text] [Related]
4. Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantaris.
Vance JC; Bart BJ; Hansen RC; Reichman RC; McEwen C; Hatch KD; Berman B; Tanner DJ
Arch Dermatol; 1986 Mar; 122(3):272-7. PubMed ID: 3954392
[TBL] [Abstract][Full Text] [Related]
5. Treatment of recurrent common warts with one low dose of intralesional natural human leukocyte interferon alpha.
Pueyo S; Criscuolo M; Davidovich C; Zorzópulos J; Pesce A; Díaz A
J Biol Regul Homeost Agents; 1990; 4(2):47-50. PubMed ID: 2260502
[TBL] [Abstract][Full Text] [Related]
6. Preventative effect of etretinate therapy on multiple actinic keratoses.
Watson AB
Cancer Detect Prev; 1986; 9(1-2):161-5. PubMed ID: 3524840
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
[TBL] [Abstract][Full Text] [Related]
8. Recombinant interferon alpha-2 (INTRON A) in a phase II study of renal cell carcinoma.
Kempf RA; Grunberg SM; Daniels JR; Skinner DG; Venturi CL; Spiegel R; Neri R; Greiner JM; Rudnick S; Mitchell MS
J Biol Response Mod; 1986 Feb; 5(1):27-35. PubMed ID: 3958753
[TBL] [Abstract][Full Text] [Related]
9. Treatment of neoplastic skin lesions with intralesional interferon.
Wickramasinghe L; Hindson TC; Wacks H
J Am Acad Dermatol; 1989 Jan; 20(1):71-4. PubMed ID: 2913082
[TBL] [Abstract][Full Text] [Related]
10. Topical application of human fibroblast interferon (IFN) in cutaneous leishmaniasis.
Trau H; Schewach-Millet M; Shoham J; Doerner T; Shor R; Passwell JH
Isr J Med Sci; 1987 Nov; 23(11):1125-7. PubMed ID: 3325468
[TBL] [Abstract][Full Text] [Related]
11. [Phase I study of human lymphoblastoid alpha-interferon on malignant tumor].
Furue H
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):977-83. PubMed ID: 3963861
[TBL] [Abstract][Full Text] [Related]
12. [Recombinant interferon alpha-2 (Sch 30500) in patients with head and neck cancer].
Miyake H; Horiuchi M; Togawa K; Kawamoto K; Kaneko T; Inuyama Y; Honda Y; Baba S; Matsunaga T; Ishikawa T
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1651-5. PubMed ID: 3896156
[TBL] [Abstract][Full Text] [Related]
13. [Phase II studies of interferon alpha-2 Sch 30500 in advanced gastrointestinal carcinoma].
Furue H
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1625-9. PubMed ID: 3896154
[TBL] [Abstract][Full Text] [Related]
14. [Behçet disease and exogenous interferon. A successful treatment study using recombinant alpha-A-IFN].
Stadler R; Bratzke B; Baumann I
Hautarzt; 1987 Feb; 38(2):97-100. PubMed ID: 3570783
[TBL] [Abstract][Full Text] [Related]
15. Sun-related factors, betapapillomavirus, and actinic keratoses: a prospective study.
McBride P; Neale R; Pandeya N; Green A
Arch Dermatol; 2007 Jul; 143(7):862-8. PubMed ID: 17638729
[TBL] [Abstract][Full Text] [Related]
16. Clinical phase II trial of recombinant DNA interferon (interferon alpha 2b) in patients with metastatic malignant melanoma.
Dorval T; Palangie T; Jouve M; Garcia-Giralt E; Israel L; Falcoff E; Schwab D; Pouillart P
Cancer; 1986 Jul; 58(2):215-8. PubMed ID: 3719515
[TBL] [Abstract][Full Text] [Related]
17. Differences in biopsy techniques of actinic keratoses by plastic surgeons and dermatologists: a histologically controlled pilot study.
Sellheyer K; Bergfeld WF
Arch Dermatol; 2006 Apr; 142(4):455-9. PubMed ID: 16618864
[TBL] [Abstract][Full Text] [Related]
18. [Interferon (IFN) therapy (recombinant IFN-alpha-2C or recombinant IFN-gamma) in metastasized hypernephroma].
Kuzmits R; Scheithauer W; Ludwig H; Flener R
Acta Med Austriaca; 1985; 12(5):129-34. PubMed ID: 3938590
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety assessment of 0.5% and 1% colchicine cream in the treatment of actinic keratoses.
Akar A; Bülent Taştan H; Erbil H; Arca E; Kurumlu Z; Gür AR
J Dermatolog Treat; 2001 Dec; 12(4):199-203. PubMed ID: 12241628
[TBL] [Abstract][Full Text] [Related]
20. Results of two sequential phase II studies of interleukin-2 (IL2) in metastatic renal cell carcinoma and melanoma: high-dose continuous intravenous IL2 infusion and subcutaneous IL2 administration in combination with alpha interferon.
Hidalgo OF; Aramendía JM; Alonso G; Foncillas JG; Brugarolas A
Rev Med Univ Navarra; 1996; 40(3):6-12. PubMed ID: 9499820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
